Arcturus Therapeutics Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. 

CEO
Joseph E. Payne
CEOJoseph E. Payne
Employees
111
Employees111
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2013
Founded2013
Employees
111
Employees111

ARCT Key Statistics

Market cap
206.64M
Market cap206.64M
Price-Earnings ratio
-2.59
Price-Earnings ratio-2.59
Dividend yield
Dividend yield
Average volume
618.71K
Average volume618.71K
High today
$8.28
High today$8.28
Low today
$7.02
Low today$7.02
Open price
$7.32
Open price$7.32
Volume
1.90M
Volume1.90M
52 Week high
$24.17
52 Week high$24.17
52 Week low
$5.85
52 Week low$5.85

Stock Snapshot

As of today, Arcturus Therapeutics Holdings(ARCT) shares are valued at $7.21. The company's market cap stands at 206.64M, with a P/E ratio of -2.59.

As of 2026-07-06, Arcturus Therapeutics Holdings(ARCT) stock has fluctuated between $7.02 and $8.28. The current price stands at $7.21, placing the stock +2.7% above today's low and -12.9% off the high.

The Arcturus Therapeutics Holdings(ARCT)'s current trading volume is 1.9M, compared to an average daily volume of 618.71K.

In the last year, Arcturus Therapeutics Holdings(ARCT) shares hit a 52-week high of $24.17 and a 52-week low of $5.85.

In the last year, Arcturus Therapeutics Holdings(ARCT) shares hit a 52-week high of $24.17 and a 52-week low of $5.85.

ARCT News

Nasdaq 3d
Arcturus Therapeutics Stock Jumps 5.7%: Will It Continue to Soar?

Arcturus Therapeutics (ARCT) shares rallied 5.7% in the last trading session to close at $7.28. This move can be attributable to notable volume with a higher nu...

Arcturus Therapeutics Stock Jumps 5.7%: Will It Continue to Soar?
TipRanks 4d
Arcturus Therapeutics Announces Thermo Fisher mRNA Partnership

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%

People also own

Based on the portfolios of people who own ARCT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.